skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Open questions: The disrupted circuitry of the cancer cell

Journal Article · · BMC Biology
 [1]
  1. Pacific Northwest National Lab. (PNNL), Richland, WA (United States)

Every new decade of biology brings with it a change in outlook driven by new technologies and fresh perspectives. Such is the case for cancer and how we consider the disease. The advent of molecular biology led to the identification of altered signaling molecules and 'oncogenes' that were proposed to drive uncontrolled cell proliferation. The rise of cell biology and new imaging and culturing technologies led to the idea that disruptions in the extracellular environment prime cells for transformation. In the current genomics era, cancer is most commonly seen as a genetic disorder where an unstable genome gives rise to a variety of different cell variants that are selected for proliferation and survival. All of these views are partially correct, of course, and are simply different ways of saying that genetic alterations in cancer cells result in a loss of growth homeostasis. They also take the view that molecular changes 'drive' a cell to grow uncontrollably, rather than tip the balance from one normal state (quiescence) to another (proliferation). Underlying this oversimplification is a profound ignorance of what controls homeostatic cell growth in the first place and how specific mutations impact it. Normal, proliferation-competent cells can accurately monitor their environment and respond appropriately to perturbation, whether it is a loss of neighbors or an inflammatory stimulus. Cancer cells either proliferate or refuse to die where and when they should not, which clearly indicates that they have problems in detecting or responding to their environment. Thus, an enormous amount of effort has gone into defining the signaling pathways that can trigger a proliferative response and the biochemical mechanisms underlying these pathways. Far less work has focused on understanding the higher-order logic of these pathways and the roles played by all of the components as part of an integrated system. In other words, we do not really understand how cells process information and make decisions and thus cannot predict how any given molecular change will alter what a cell does.

Research Organization:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
AC05-76RL01830
OSTI ID:
1208943
Journal Information:
BMC Biology, Vol. 12, Issue 1; ISSN 1741-7007
Publisher:
BioMed CentralCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 1 work
Citation information provided by
Web of Science

References (12)

Recurrent design patterns in the feedback regulation of the mammalian signalling network journal January 2008
Genomic Sequencing for Cancer Diagnosis and Therapy journal January 2014
The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier journal December 2010
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis journal January 2006
The Hallmarks of Cancer journal January 2000
Linking Proteomic and Transcriptional Data through the Interactome and Epigenome Reveals a Map of Oncogene-induced Signaling journal February 2013
IGF binding proteins in cancer: mechanistic and clinical insights journal April 2014
Structure of the EGF receptor transactivation circuit integrates multiple signals with cell context journal January 2010
Feedback regulation of EGFR signalling: decision making by early and delayed loops journal January 2011
Putting tumours in context journal October 2001
Computational modeling of the EGF-receptor system: a paradigm for systems biology journal January 2003
Negative Feedback and Adaptive Resistance to the Targeted Therapy of Cancer journal March 2012

Cited By (2)

Cancer drug target identification and node-level analysis of the network of MAPK pathways journal March 2018
Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma journal March 2015

Similar Records

Open questions: The disrupted circuitry of the cancer cell
Journal Article · Fri Oct 24 00:00:00 EDT 2014 · BMC Biology · OSTI ID:1208943

Disrupted NOS2 metabolism drives myoblast response to wasting-associated cytokines
Journal Article · Fri Oct 15 00:00:00 EDT 2021 · Experimental Cell Research · OSTI ID:1208943

59. Cold Spring Harbor symposium on quantitative biology: Molecular genetics of cancer
Conference · Sat Dec 31 00:00:00 EST 1994 · OSTI ID:1208943

Related Subjects